Riskpilot← Back to searchSign inGet full accessPHARMAVIT ApS
APSIn liquidationCVR 29316775Frederiksværkvej 142Wholesale of other food · NACE 4638Est. 20061 employees
Revenue 2024
DKK -11K
-105% vs 2023
EBITDA margin
100.0%
-105% vs 2023
Equity ratio
97.3%
Financial strength
Net profit 2024
DKK -2K
-100% vs 2023
| Revenue | DKK -11K | -105% |
| EBITDA | DKK -11K | -105% |
| Net profit | DKK -2K | -100% |
| Total assets | DKK 405K | -16% |
| Equity | DKK 394K | +0% |
| Employees | 1 | — |
Legal name
PHARMAVIT ApS
CVR number
29316775
Legal form
Anpartsselskab
NACE code
4638 · Wholesale of other food
Founded
20. januar 2006
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Frederiksværkvej 142
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 766 | 889 | 1.155 | 216 | -11 |
| Staff expenses | -434 | -629 | -762 | -0 | -0 |
| EBITDA | 332 | 269 | 393 | 216 | -11 |
| Depreciation & amort. | -6 | 4 | -0 | -0 | -0 |
| EBIT | 326 | 264 | 393 | 216 | -11 |
| Net financials | 234 | 294 | 386 | 3.217 | 14 |
| Profit before tax | 560 | 558 | 779 | 3.433 | 3 |
| Tax | 60 | 50 | 71 | 76 | 5 |
| Net profit | 500 | 509 | 708 | 3.357 | -2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.395 | 3.185 | 5.116 | 482 | 405 |
| Equity | 1.423 | 1.932 | 2.640 | 396 | 394 |
| Long-term debt | 0 | 0 | 5 | 0 | 0 |
| Short-term debt | 971 | 1.252 | 2.471 | 86 | 11 |
| Total debt | 971 | 1.252 | 2.476 | 86 | 11 |
EBITDA margin
-1111400.0%
This company
15.8%
Market median
-7034277% vs market
20202024
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20202024
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
20202024
Net profit margin
-188600.0%
This company
8.1%
Market median
-2328495% vs market
20202024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
RL Management | Management | 2006 – 2024 |
PA Management | Management | 2006 – 2006 |
SR Unofficial title | Unofficial title | 2024 – 2025 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2006 | |
| Individual | 50–66.65% | 50–66.65% | 2006 | |
| Individual | 100% | 100% | 2023 | |
| Individual | 50–66.65% | 50–66.65% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PHARMAVIT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ronald Leonard Schmid | Management | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Sebastian Rungby | Unofficial title | 0 companies |